Investment Column: Rexam's recovery still has some fizz


Our view: buy

Share price: 372p (-0.5p)

The packaging company Rexam highlighted the scale of its ambition in Brazil yesterday by unveiling plans for a new beverage plant in the country's northern region.

The new plant will be operational by the middle of next year and Rexam says it will have a capacity of 1.2 billion cans. This will help the group, which makes cans for Carlsberg and Red Bull, achieve total capacity of 14 billion cans by the end of 2012, up from 11 billion at the start of this year.

The move reaffirmed Rexam's long-term commitment to Brazil, one of the fast-growing BRIC countries, alongside Russia, India and China.

However, Brazil is just one part of the recovery story at Rexam, which has around a 100 plants in more than 20 countries, following a slump during the recession. The group was forced to launch a £350m rights issue in July 2009 and canned its interim dividend after it posted a £30m half-year loss.

As consumers tightened their purse strings, the City was also concerned about Rexam's debt mountain. Since the fund-raising, however, the group has been busy turning around its sales and profits.

In February, it reported a 45 per cent uplift in underlying profits to £412m for 2010, aided by a tight leash on costs. The company is reducing its net debt, and highlighted its return to form with a total dividend of 12p.

We think this recovery story still has legs and, coupled with the affordable valuation of under 11 times forward earnings, leaves ample scope for upside gains.

RWS Holdings

Our view: buy

Share price: 400.1p (+15.5p)

As we have remarked before, RWS does not lend itself to easy comparisons. It occupies a niche, searching and translating patents and providing other intellectual property-related services. On the upside, however, this specialist focus has helped it to secure a leading position in what the analysts at Peel Hunt characterise as "a global, stable and growing market".

Yesterday's half-yearly trading update confirmed the group's strengths, with revenues rising by a healthy 10 per cent. The performance was underpinned by a strong showing from the group's translation business, which accounts for around 70 per cent of revenues.

But should you buy? The lack of comparisons with other companies does not help and makes us cautious. That said, RWS is clearly performing well, boasts a strong balance sheet with nearly £20m in net cash at the end of March and, in what we see as the clincher, trades on a thin enterprise multiple of under 4 times. Throw in the robust prospective yield of around 4 per cent, and we reckon this stock could be well worth a punt.

Start your day with The Independent, sign up for daily news emails
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Guru Careers: Communications Exec / PR Exec

£25 - £30K: Guru Careers: We are seeking a highly-motivated and ambitious Comm...

Guru Careers: Pricing Analyst

£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...

Day In a Page

On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back
Thurston Moore interview

Thurston Moore interview

On living in London, Sonic Youth and musical memoirs
In full bloom

In full bloom

Floral print womenswear
From leading man to Elephant Man, Bradley Cooper is terrific

From leading man to Elephant Man

Bradley Cooper is terrific
In this the person to restore our trust in the banks?

In this the person to restore our trust in the banks?

Dame Colette Bowe - interview
When do the creative juices dry up?

When do the creative juices dry up?

David Lodge thinks he knows
The 'Cher moment' happening across fashion just now

Fashion's Cher moment

Ageing beauty will always be more classy than all that booty
Thousands of teenage girls enduring debilitating illnesses after routine school cancer vaccination

Health fears over school cancer jab

Shock new Freedom of Information figures show how thousands of girls have suffered serious symptoms after routine HPV injection
Fifa President Sepp Blatter warns his opponents: 'I forgive everyone, but I don't forget'

'I forgive everyone, but I don't forget'

Fifa president Sepp Blatter issues defiant warning to opponents
Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report

Weather warning

Extreme summer temperatures will soon cause deaths of up to 1,700 more Britons a year, says government report
LSD: Speaking to volunteer users of the drug as trials get underway to see if it cures depression and addiction

High hopes for LSD

Meet the volunteer users helping to see if it cures depression and addiction
German soldier who died fighting for UK in Battle of Waterloo should be removed from museum display and given dignified funeral, say historians

Saving Private Brandt

A Belgian museum's display of the skeleton of a soldier killed at Waterloo prompts calls for him to be given a dignified funeral